CA1322743C - Systeme et methode de distribution de fluides multiples - Google Patents

Systeme et methode de distribution de fluides multiples

Info

Publication number: CA1322743C
Authority: CA; Canada
Prior art keywords: fluid; flow; patient; fluids; occluder
Prior art date: 1987-08-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA000616185A

Other languages

English (en)

Inventor

Theodore Liber

Kimball J. Knowlton

Charles R. Smith

Albin Huntley

Frederic Irwin Orkin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Baxter International Inc

Original Assignee

Baxter International Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-08-07

Filing date

1991-09-26

Publication date

1993-10-05

1987-08-07 Priority claimed from US07/083,843 external-priority patent/US4925444A/en

1991-09-26 Application filed by Baxter International Inc filed Critical Baxter International Inc

1993-10-05 Application granted granted Critical

1993-10-05 Publication of CA1322743C publication Critical patent/CA1322743C/fr

2008-07-29 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000012530 fluid Substances 0.000 title claims abstract description 382
238000000034 method Methods 0.000 title description 37
230000004044 response Effects 0.000 claims description 11
238000013459 approach Methods 0.000 claims description 2
238000007789 sealing Methods 0.000 claims 1
238000001990 intravenous administration Methods 0.000 abstract description 5
230000003993 interaction Effects 0.000 abstract description 4
229940079593 drug Drugs 0.000 description 105
239000003814 drug Substances 0.000 description 105
239000000243 solution Substances 0.000 description 38
230000006870 function Effects 0.000 description 27
238000001802 infusion Methods 0.000 description 18
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 14
238000010586 diagram Methods 0.000 description 14
230000008569 process Effects 0.000 description 13
230000008878 coupling Effects 0.000 description 10
238000010168 coupling process Methods 0.000 description 10
238000005859 coupling reaction Methods 0.000 description 10
230000008859 change Effects 0.000 description 9
230000002829 reductive effect Effects 0.000 description 9
150000002500 ions Chemical class 0.000 description 8
239000007788 liquid Substances 0.000 description 8
238000012360 testing method Methods 0.000 description 8
239000007789 gas Substances 0.000 description 7
230000001965 increasing effect Effects 0.000 description 7
239000001103 potassium chloride Substances 0.000 description 7
235000011164 potassium chloride Nutrition 0.000 description 7
230000009471 action Effects 0.000 description 5
239000002674 ointment Substances 0.000 description 5
239000008280 blood Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
238000004891 communication Methods 0.000 description 4
239000002131 composite material Substances 0.000 description 4
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
238000005086 pumping Methods 0.000 description 4
238000012546 transfer Methods 0.000 description 4
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
230000000903 blocking effect Effects 0.000 description 3
238000004140 cleaning Methods 0.000 description 3
230000001276 controlling effect Effects 0.000 description 3
238000012377 drug delivery Methods 0.000 description 3
229940063190 flagyl Drugs 0.000 description 3
238000011010 flushing procedure Methods 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
238000007726 management method Methods 0.000 description 3
238000002483 medication Methods 0.000 description 3
FPTPAIQTXYFGJC-UHFFFAOYSA-N metronidazole hydrochloride Chemical group Cl.CC1=NC=C([N+]([O-])=O)N1CCO FPTPAIQTXYFGJC-UHFFFAOYSA-N 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000002572 peristaltic effect Effects 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
230000008093 supporting effect Effects 0.000 description 3
229960000707 tobramycin Drugs 0.000 description 3
NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 3
230000007704 transition Effects 0.000 description 3
210000003462 vein Anatomy 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
230000036772 blood pressure Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
230000006835 compression Effects 0.000 description 2
238000007906 compression Methods 0.000 description 2
230000000881 depressing effect Effects 0.000 description 2
239000008121 dextrose Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
229960003638 dopamine Drugs 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000005484 gravity Effects 0.000 description 2
230000036541 health Effects 0.000 description 2
239000012678 infectious agent Substances 0.000 description 2
239000003978 infusion fluid Substances 0.000 description 2
238000009434 installation Methods 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
230000000474 nursing effect Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
208000030507 AIDS Diseases 0.000 description 1
208000010444 Acidosis Diseases 0.000 description 1
241000518994 Conta Species 0.000 description 1
101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
235000002046 Hedeoma drummondii Nutrition 0.000 description 1
244000139725 Hedeoma drummondii Species 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
241001508687 Mustela erminea Species 0.000 description 1
101800000989 Oxytocin Proteins 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
241000613130 Tima Species 0.000 description 1
230000007950 acidosis Effects 0.000 description 1
208000026545 acidosis disease Diseases 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000007815 allergy Effects 0.000 description 1
238000005576 amination reaction Methods 0.000 description 1
FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
229960003556 aminophylline Drugs 0.000 description 1
230000036592 analgesia Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000004397 blinking Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000002844 continuous effect Effects 0.000 description 1
230000008602 contraction Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
238000001514 detection method Methods 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
VJECBOKJABCYMF-UHFFFAOYSA-N doxazosin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 VJECBOKJABCYMF-UHFFFAOYSA-N 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000002651 drug therapy Methods 0.000 description 1
239000003792 electrolyte Substances 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000002458 fetal heart Anatomy 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
229960005181 morphine Drugs 0.000 description 1
230000005405 multipole Effects 0.000 description 1
239000004081 narcotic agent Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
230000036407 pain Effects 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
229940030215 pitocin Drugs 0.000 description 1
239000004033 plastic Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000007639 printing Methods 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
238000009666 routine test Methods 0.000 description 1
239000004065 semiconductor Substances 0.000 description 1
239000012086 standard solution Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000002227 vasoactive effect Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1

Landscapes

Infusion, Injection, And Reservoir Apparatuses (AREA)

CA000616185A 1987-08-07 1991-09-26 Systeme et methode de distribution de fluides multiples Expired - Fee Related CA1322743C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US083,843		1987-08-07
US07/083,843 US4925444A (en)	1987-08-07	1987-08-07	Closed multi-fluid delivery system and method
CA000573511A CA1317007C (fr)	1987-08-07	1988-07-29	Methode et systeme ferme de distribution de fluides multiples

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000573511A Division CA1317007C (fr)	1987-08-07	1988-07-29	Methode et systeme ferme de distribution de fluides multiples

Publications (1)

Publication Number	Publication Date
CA1322743C true CA1322743C (fr)	1993-10-05

Family

ID=25672023

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA000616185A Expired - Fee Related CA1322743C (fr)	1987-08-07	1991-09-26	Systeme et methode de distribution de fluides multiples
CA000616180A Expired - Fee Related CA1327499C (fr)	1987-08-07	1991-09-26	Methode et systeme ferme de distribution de fluides multiples

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
CA000616180A Expired - Fee Related CA1327499C (fr)	1987-08-07	1991-09-26	Methode et systeme ferme de distribution de fluides multiples

Country Status (1)

Country	Link
CA (2)	CA1322743C (fr)

1991
- 1991-09-26 CA CA000616185A patent/CA1322743C/fr not_active Expired - Fee Related
- 1991-09-26 CA CA000616180A patent/CA1327499C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA1327499C (fr)	1994-03-08

Legal Events

Date	Code	Title	Description
2005-10-05	MKLA	Lapsed

Publication	Publication Date	Title
US4925444A (en)	1990-05-15	Closed multi-fluid delivery system and method
US5207642A (en)	1993-05-04	Closed multi-fluid delivery system and method
CA1319068C (fr)	1993-06-15	Configuration multimode pour systeme d'infusions medicamenteuses
US12599716B2 (en)	2026-04-14	Intravenous infusion pump with cassette insertion and pump control user interface
US20230398286A1 (en)	2023-12-14	Systems and methods for substantially continuous intravenous infusion of the same or substantially the same medical fluid with fluid source replacements
US4919596A (en)	1990-04-24	Fluid delivery control and monitoring apparatus for a medication infusion system
US20220401640A1 (en)	2022-12-22	Intravenous infusion pumps with system and pharmacodynamic model adjustment for display and operation
JPS62114562A (ja)	1987-05-26	点滴投与装置
EP1082154A1 (fr)	2001-03-14	Conduit d'elastomere moule d'une piece s'utilisant avec une pompe medicale de perfusion
JPH05237186A (ja)	1993-09-17	患者の循環系に流体を投与する注入システム
JPH01297076A (ja)	1989-11-30	薬剤注入システムのための流体供給制御／モニタリング装置
CA1322743C (fr)	1993-10-05	Systeme et methode de distribution de fluides multiples
KR940011440B1 (ko)	1994-12-15	인퓨션펌프
Webb	1981	Contemporary comments on infusion pumps
Weinstein	1981	Nursing considerations: Flow control
NOBEL	1995	Syringe infusion pumps